CMS Rules against FDG-PET
Coverage for Fever and Infection
CMS ruled that it would not extend Medicare coverage for
FDG-PET for three indications: chronic osteomyelitis, infection
of hip arthroplasty and fever of unknown origin fever because
the evidence is inadequate to conclude that FDG-PET improves
health outcomes in the Medicare population. Therefore, they will
be continuing the national noncoverage of FDG- PET for these
indications. CMS also has determined that the request for
coverage is not appropriate for the Coverage with Evidence
Development (CED) paradigm.
The decision memo can be found at:
http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=207 |